Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016; New Report Launched
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016 report provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Wet (Neovascular / Exudative) Macular Degeneration, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and...
View full press release